SCHEMBL5849470

SCHEMBL5849470

N=C(N)NCCCC(NC(=O)CNC(=O)C(N)CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 2/20 0.40
CXCR4 P61073 2/20 0.39
NPY4R P50391 5/20 0.39
NPY1R P25929 4/20 0.39
NPY2R P49146 4/20 0.39
NPY5R Q15761 4/20 0.39
GNPAT O15228 1/20 0.38
QRFPR Q96P65 1/20 0.37
TFPI P10646 1/20 0.36
KEAP1 Q14145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5849482 1.00 OPRL1 (0.40) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL13496859 0.93 NPY4R (0.40) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL7394659 0.93 NPY4R (0.40) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL31410639 0.92 NPY4R (0.47) CXCR4NPY4RNPY1RNPY2RNPY5R
SCHEMBL29489381 0.92 OPRL1 (0.44) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL30753507 0.91 PTGS1 (0.40) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL25639021 0.91 PTGS1 (0.40) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL29647783 0.91 PTGS1 (0.40) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL17440322 0.91 QRFPR (0.42) OPRL1CXCR4NPY4RNPY1RNPY2R
SCHEMBL13319653 0.91 QRFPR (0.42) OPRL1CXCR4NPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087722-B1 Fibrin binding domain polypeptides and uses and methods of producing same SAVIENT PHARMACEUTICALS, INC. (US) 2006-08-08 US disclosed
US-6121426-A IMAGING POLYPEPTIDE LABELED WITH A MARKER; FOR THE PREVENTION OF INFECTION AND SEPSIS IN WOUNDS; FOR THE DETECTION OF ATHEROSCLEROTIC PLAQUES OR THROMBUS BIO-TECHNOLOGY GENERAL CORP. (US) 2000-09-19 US disclosed
US-5965383-A IMAGING AGENT OF A LABELED POLYPEPTIDE WHICH IS A FIBRIN BINDING DOMAIN FROM FIBRONECTIN; FOR DIAGNOSIS OF ATHLEROSCLEROTIC PLAQUE AND THROMBI BIO-TECHNOLOGY GENERAL CORP. (US) 1999-10-12 US disclosed
EP-0651799-B1 FIBRIN BINDING DOMAIN POLYPEPTIDES AND USES AND METHODS OF PRODUCING SAME BIO TECHNOLOGY GENERAL CORP (US) 1999-08-18 EP disclosed
US-5869616-A IMAGING AGENT COMPOSED OF N-TERMINAL AMINO ACID SEQUENCE OF FIBRONECTIN AND LABEL; FOR NONINVASIVE, ACCURATE DIAGNOSIS OF A THROMBUS OR ATHEROSCLEROTIC PLAQUE BIO-TECHNOLOGY GENERAL CORP. (US) 1999-02-09 US disclosed
US-5679320-A IMAGING FIBRIN CONTAINING SUBSTANCE BY CONTACTING WITH POLYPEPTIDE HAVING AMINO ACID SEQUENCE IDENTICAL TO FIBRIN BINDING DOMAIN OF HUMAN FIBRONECTIN LABELED WITH IMAGEABLE MARKER BIO-TECHNOLOGY GENERAL CORP. (US) 1997-10-21 US disclosed
US-5455158-A Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin BIO-TECHNOLOGY GENERAL CORP. (US) 1995-10-03 US disclosed
EP-0651799-A1 FIBRIN BINDING DOMAIN POLYPEPTIDES AND USES AND METHODS OF PRODUCING SAME BIO-TECHNOLOGY GENERAL CORPORATION (US) 1995-05-10 EP disclosed
US-5270030-A Fibrin binding domain polypeptide and method of producing BIO-TECHNOLOGY GENERAL CORP. (US) 1993-12-14 US disclosed
EP-0651799-A4 FIBRIN BINDING DOMAIN POLYPEPTIDES AND USES AND METHODS OF PRODUCING SAME. BIO TECHNOLOGY GENERAL CORP (US) 1993-10-05 EP disclosed
WO-1991017765-A1 FIBRIN BINDING DOMAIN POLYPEPTIDES AND USES AND METHODS OF PRODUCING SAME BIO-TECHNOLOGY GENERAL CORP. (US) 1991-11-28 WO disclosed